Ego Pharmaceuticals boosts local skincare manufacturing
Australian skincare maker Ego Pharmaceuticals is doubling local production following a $156 million investment in its local manufacturing.
Aussie medical tech scores big win in US market
Cyclopharm’s lung imaging technology is breathing new life into the company’s bottom line, with its Technegas product surpassing the million-dollar milestone in US sales, according to Tuesday’s ASX announcement. The Sydney-based company has rapidly expanded its American footprint, with Technegas systems now installed in 27 US medical facilities as of 31 March 2025 – a…
Australia’s only IV fluids maker gets gov boost
The Federal Government is pouring $20 million into IV fluids maker, Baxter Healthcare, to expand its manufacturing capability.
Call for homegrown medicine production as penicillin imports dry up
A critical shortage of an essential penicillin medication is highlighting Australia’s vulnerability in pharmaceutical manufacturing, according to a new report published in the Medical Journal of Australia on Monday. The medication, benzathine benzylpenicillin G (BPG), is vital for treating syphilis and preventing rheumatic heart disease, conditions that disproportionately affect Aboriginal and Torres Strait Islander communities.…
Vaxxas completes enrolment for needle-free vaccine patch trial
Brisbane biotechnology company Vaxxas has completed enrolment for testing a needle-free vaccine patch against avian influenza.
Biome Australia reports first net profit, expands distribution network
Biome Australia announced its first net profit on Sunday, reporting $96,228 (excluding R&D rebate) for the first half of FY25, alongside record half-year sales revenue of $8.86 million. The microbiome health company reported positive EBITDA of $351,765 for H1 FY25, with Q2 showing an 89 per cent increase to $229,917 compared to Q1. Including R&D…
WA gov to kickstart medical start-ups
The West Australian government has provided $4.3 million in seed funding for health and medical start-ups to boost the sector’s manufacturing in the state. Nine companies will receive support from the 2022-23 Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund, which will help them develop and commercialise their projects, as well as enhance…
Blackmores – the latest to fall to foreign takeover
By Peter Roberts Sydney vitamin manufacturer Blackmores has fallen victim to foreign takeover and will be removed from listing on the ASX. Japanese company Kirin Holdings, best known as a beer and beverage group, is to buy the company in a takeover valuing the business at $1.8 billion. The friendly takeover by the member of…